Total Funding
64
62
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
74957
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
- Bent Jakobsen: Founder & Board MemberPast Role: Immunocore, Chief Scientific Officer
- Dan Williams: CEO, Executive Director and Co-founderPast Role: Danes Consultants, Director and Founder
About the Company
SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.
